STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
23.30
-0.22 (-0.94%)
Sep 2, 2026, 12:03 PM EDT - Market open
STAAR Surgical Company Ratios and Metrics
Market cap in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jan '26 Jan 2, 2026 | Dec '24 Dec 27, 2024 | Dec '23 Dec 29, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 31, 2021 |
| 1,168 | 1,174 | 1,193 | 1,523 | 2,340 | 4,346 | |
Market Cap Growth | -13.83% | -1.57% | -21.71% | -34.90% | -46.16% | 19.00% |
Enterprise Value | 1,023 | 1,020 | 997 | 1,371 | 2,158 | 4,173 |
Last Close Price | 23.52 | 23.60 | 24.21 | 31.21 | 48.54 | 91.30 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jan '26 Jan 2, 2026 | Dec '24 Dec 27, 2024 | Dec '23 Dec 29, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 304.40 | - | - | 71.36 | 58.99 | 157.96 |
Forward PE | 27.27 | 46.83 | 34.67 | 31.21 | 41.44 | 99.97 |
PS Ratio | 3.44 | 4.90 | 3.80 | 4.72 | 8.23 | 18.86 |
PB Ratio | 3.23 | 3.41 | 3.00 | 3.95 | 6.96 | 16.81 |
P/TBV Ratio | 3.52 | 3.77 | 3.14 | 3.97 | 7.00 | 16.94 |
P/FCF Ratio | - | - | - | - | 132.89 | 143.34 |
P/OCF Ratio | - | - | 75.84 | 104.37 | 65.51 | 98.85 |
PEG Ratio | - | 0.93 | 1.16 | 1.04 | 1.38 | 3.33 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jan '26 Jan 2, 2026 | Dec '24 Dec 27, 2024 | Dec '23 Dec 29, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.01 | 4.26 | 3.18 | 4.25 | 7.59 | 18.11 |
EV/EBITDA Ratio | 20.56 | - | - | 39.36 | 44.22 | 113.15 |
EV/EBIT Ratio | 24.80 | - | - | 46.15 | 48.72 | 125.55 |
EV/FCF Ratio | - | - | - | - | 122.58 | 137.64 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jan '26 Jan 2, 2026 | Dec '24 Dec 27, 2024 | Dec '23 Dec 29, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.10 | 0.11 | 0.10 | 0.09 | 0.09 | 0.12 |
Debt / EBITDA Ratio | 0.62 | - | 12.43 | 0.89 | 0.58 | 0.80 |
Debt / FCF Ratio | - | - | - | - | 1.76 | 1.06 |
Net Debt / Equity Ratio | -0.40 | -0.43 | -0.48 | -0.48 | -0.54 | -0.65 |
Net Debt / EBITDA Ratio | -2.92 | 3.99 | 35.13 | -5.31 | -3.70 | -4.55 |
Net Debt / FCF Ratio | 21.57 | 3.73 | 25.00 | 51.45 | -10.26 | -5.53 |
Asset Turnover | 0.74 | 0.50 | 0.63 | 0.71 | 0.74 | 0.76 |
Inventory Turnover | 1.59 | 1.15 | 1.90 | 2.35 | 2.95 | 2.93 |
Quick Ratio | 3.86 | 3.53 | 4.41 | 4.90 | 5.37 | 5.05 |
Current Ratio | 4.67 | 4.55 | 5.23 | 5.62 | 6.03 | 5.56 |
Return on Equity (ROE) | 1.09% | -21.70% | -5.16% | 5.91% | 13.34% | 12.07% |
Return on Assets (ROA) | 5.65% | -5.95% | -1.55% | 4.09% | 7.24% | 6.89% |
Return on Invested Capital (ROIC) | 4.09% | -22.84% | -6.07% | 10.56% | 31.31% | 39.88% |
Return on Capital Employed (ROCE) | 10.30% | -11.90% | -2.80% | 7.00% | 12.10% | 11.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jan '26 Jan 2, 2026 | Dec '24 Dec 27, 2024 | Dec '23 Dec 29, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.33% | -6.85% | -1.69% | 1.40% | 1.70% | 0.63% |
FCF Yield | -0.58% | -3.41% | -0.64% | -0.24% | 0.75% | 0.70% |
Buyback Yield / Dilution | -2.37% | -0.90% | 0.61% | -0.10% | 0.15% | -3.13% |